OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Advisory Board and Contents	228
Subscription and Copyright Information	220
Subscription and Copyright Information	198
Advisory Board and Contents	193
Stories in Molecular Medicine December 2021	186
Subscription and Copyright Information	156
Advisory Board and Contents	156
Advisory Board and Contents	149
Subscription and Copyright Information	123
Subscription and Copyright Information	121
m6A and beyond: RNA modifications shaping angiogenesis	118
Fc-optimized checkpoint antibodies for cancer immunotherapy	115
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	110
Pushing the boundaries of brain organoids to study Alzheimer’s disease	109
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates	101
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	100
Consideration of the importance of measuring thermal discomfort in biomedical research	100
Neutrophils and extracellular traps in crystal-associated diseases	95
Opportunities and challenges for biomarker discovery using electronic health record data	89
Beneath the radar: immune-evasive cell sources for stroke therapy	88
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	87
d-Amino acids: new clinical pathways for brain diseases	79
Subscription and Copyright Information	76
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	76
Stories in Molecular Medicine November 2021	73

Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	68
Insights from HIV-1 vaccine and passive immunization efficacy trials	67
Brain-specific regulatory T cell expansion limits cognitive decline	67
Engineering cytokines for tumor-targeting and selective T cell activation	66
Acquired resistance to immunotherapy in solid tumors	64
Erythropoietic protoporphyrias: updates and advances	63
Amyloid and collagen templates in aortic valve calcification	63
Molecular mechanisms in the pathogenesis of dengue infections	61
Three ‘E’ challenges for siRNA drug development	60
iPSCs and DRGs: stepping stones to new pain therapies	54
Cell-free circulating tumor DNA profiling in cancer management	53
Microbes and mood: innovative biomarker approaches in depression	53
Advisory Board and Contents	52
Emerging roles of cyclin-dependent kinase 7 in health and diseases	51
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments	49
Keratinocytes: new perspectives in inflammatory skin diseases	49
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	48
Hormesis as an adaptive response to infection	46
Epigenetic regulation in intervertebral disc degeneration	46
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	45